| Chronic mild stress-induced anhedonia: a realistic animal model of depression P Willner, R Muscat, M Papp Neuroscience & Biobehavioral Reviews 16 (4), 525-534, 1992 | 1458 | 1992 |
| An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress M Papp, P Willner, R Muscat Psychopharmacology 104, 255-259, 1991 | 650 | 1991 |
| Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression MN Jayatissa, C Bisgaard, A Tingström, M Papp, O Wiborg Neuropsychopharmacology 31 (11), 2395-2404, 2006 | 419 | 2006 |
| Effect of agomelatine in the chronic mild stress model of depression in the rat M Papp, P Gruca, PA Boyer, E Mocaër Neuropsychopharmacology 28 (4), 694-703, 2003 | 363 | 2003 |
| Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression M Papp, E Moryl European journal of pharmacology 263 (1-2), 1-7, 1994 | 324 | 1994 |
| Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline R Muscat, M Papp, P Willner Psychopharmacology 109, 433-438, 1992 | 304 | 1992 |
| S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine … MJ Millan, A Gobert, F Lejeune, A Newman-Tancredi, JM Rivet, A Auclair, ... Journal of Pharmacology and Experimental Therapeutics 298 (2), 565-580, 2001 | 272* | 2001 |
| Pharmacological validation of the chronic mild stress model of depression M Papp, E Moryl, P Willner European journal of pharmacology 296 (2), 129-136, 1996 | 268 | 1996 |
| Decreased hedonic responsiveness following chronic mild stress is not secondary to loss of body weight P Willner, JL Moreau, CK Nielsen, M Papp, A Sluzewska Physiology & Behavior 60 (1), 129-134, 1996 | 251 | 1996 |
| Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine M Papp, V Klimek, P Willner Psychopharmacology 115, 441-446, 1994 | 242 | 1994 |
| Escitalopram (S‐enantiomer of citalopram): Clinical efficacy and onset of action predicted from a rat model SA Montgomery, H Loft, C Sánchez, EH Reines, M Papp Pharmacology & toxicology 88 (5), 282-286, 2001 | 207 | 2001 |
| Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety M Papp, E Litwa, P Gruca, E Mocaër Behavioural pharmacology 17 (1), 9-18, 2006 | 186 | 2006 |
| Effect of chronic mild stress on circadian rhythms in the locomotor activity in rats Z Gorka, E Moryl, M Papp Pharmacology Biochemistry and behavior 54 (1), 229-234, 1996 | 160 | 1996 |
| Antidepressant-like effects of dopamine agonists in an animal model of depression R Muscat, M Papp, P Willner Biological psychiatry 31 (9), 937-946, 1992 | 151 | 1992 |
| S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models A Dekeyne, C Mannoury la Cour, A Gobert, M Brocco, F Lejeune, F Serres, ... Psychopharmacology 199, 549-568, 2008 | 147 | 2008 |
| Antidepressant-like activity of zinc: further behavioral and molecular evidence M Sowa-Kućma, B Legutko, B Szewczyk, K Novak, P Znojek, E Poleszak, ... Journal of neural transmission 115, 1621-1628, 2008 | 137 | 2008 |
| Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression M Papp, V Klimek, P Willner Psychopharmacology 114, 309-314, 1994 | 136 | 1994 |
| Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment M Dziedzicka-Wasylewska, P Willner, M Papp Behavioural pharmacology 8 (6), 607-618, 1997 | 132 | 1997 |
| Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression M Papp, E Moryl European journal of pharmacology 316 (2-3), 145-151, 1996 | 130* | 1996 |
| An animal model of anhedonia P Willner, R Muscat, M Papp Clinical neuropharmacology 15 (Part A), 550A-551A, 1992 | 127 | 1992 |
